WHO ICTRP trial
Effects of supplementation with orally effective Superoxide Dismutase, GliSODin…
ACTRN12622000319774 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12622000319774 |
|---|---|
| Public title | Effects of supplementation with orally effective Superoxide Dismutase, GliSODin, on oxidative stress, inflammation and performance in athletes |
| Scientific title | Evaluation of antioxidant and anti-inflammatory properties of orally effective plant origin Superoxide Dismutase, GliSODin, supplementation and its impact on performance in athletes |
| Primary sponsor | Ivan Stankovic |
| Secondary sponsors | Milivoj Dopsaj |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Serbia and Montenegro |
| Conditions | Exercise performance ;Exercise induced oxidative stress;Exercise induced inflammation; Exercise performance Exercise induced oxidative stress Exercise induced inflammation;Alternative and Complementary Medicine - Other alternative and… |
| Interventions | Supplementation with plant origin superoxide dismutase (GliSODin) in a randomized, double-blind, placebo controlled study conducted to assess the effects of supplementation on exercise-induced oxidative stress, exercise-induced inflammation… |
| Registration date | Feb 21, 2022 |
| Target size | 60 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: